ciprofloxacin has been researched along with Pachymeningitis in 24 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the entry of ciprofloxacin into the cerebrospinal fluid (CSF) in 37 patients with various types of meningitis (bacterial meningitis 10 patients, viral 12 patients, tuberculous 7 patients)." | 7.68 | Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis. ( Barsić, B; Beus, I; Himbele, J; Lisić, M; Marton, E; Schönwald, S, 1991) |
| "The potential of ciprofloxacin for the therapy of Pseudomonas aeruginosa meningitis was evaluated in an animal model by determining the penetration of the drug into CSF, its concentration-dependent killing characteristics in vivo, and its relative efficacy compared with ceftazidime and tobramycin." | 7.67 | Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. ( Chambers, HF; Hackbarth, CJ; Sande, MA; Shibl, AM; Stella, F, 1986) |
| "We evaluated the diffusion of ciprofloxacin into the cerebrospinal fluid (CSF) in 23 patients with bacterial meningitis or ventriculitis undergoing treatment with other antibiotics." | 7.67 | Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. ( Boutron, L; Clair, B; Decazes, JM; Regnier, B; Singlas, E; Wolff, M, 1987) |
| "Underlying clinical syndromes were viral meningitis (n = 10), convalescent phase of acute bacterial meningitis (n = 9), and acute phase of bacterial meningitis (n = 1)." | 5.28 | Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis. ( Borner, K; Ruhnke, M; Trautmann, M, 1990) |
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 5.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| "We studied the entry of ciprofloxacin into the cerebrospinal fluid (CSF) in 37 patients with various types of meningitis (bacterial meningitis 10 patients, viral 12 patients, tuberculous 7 patients)." | 3.68 | Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis. ( Barsić, B; Beus, I; Himbele, J; Lisić, M; Marton, E; Schönwald, S, 1991) |
| "The potential of ciprofloxacin for the therapy of Pseudomonas aeruginosa meningitis was evaluated in an animal model by determining the penetration of the drug into CSF, its concentration-dependent killing characteristics in vivo, and its relative efficacy compared with ceftazidime and tobramycin." | 3.67 | Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. ( Chambers, HF; Hackbarth, CJ; Sande, MA; Shibl, AM; Stella, F, 1986) |
| "We evaluated the diffusion of ciprofloxacin into the cerebrospinal fluid (CSF) in 23 patients with bacterial meningitis or ventriculitis undergoing treatment with other antibiotics." | 3.67 | Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. ( Boutron, L; Clair, B; Decazes, JM; Regnier, B; Singlas, E; Wolff, M, 1987) |
| "Tularemia is a zoonotic disease caused by Francisella tularensis." | 2.45 | Tularemic meningitis in the United States. ( Cardona, L; Davis, LE; Hofinger, DM; Mertz, GJ, 2009) |
| "Escherichia coli meningitis is a frequent pathology in children younger than 3 years old, but is an uncommon disease in adults." | 1.33 | E. coli multiresistant meningitis after transrectal prostate biopsy. ( Alecsandru, D; Garcia, A; Gestoso, I; Lobo, J; Martinez, A; Romero, A; Yagüe, MR, 2006) |
| "Fleroxacin was inactive against S." | 1.28 | In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin. ( Beskid, G; Chan, K; Cleeland, R; Keith, DD; McGarry, CM; Siebelist, J, 1990) |
| "Underlying clinical syndromes were viral meningitis (n = 10), convalescent phase of acute bacterial meningitis (n = 9), and acute phase of bacterial meningitis (n = 1)." | 1.28 | Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis. ( Borner, K; Ruhnke, M; Trautmann, M, 1990) |
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 1.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Mäki-Koivisto, V | 1 |
| Korkala, M | 1 |
| Simola, L | 1 |
| Suutari-Kontio, S | 1 |
| Koivunen, S | 1 |
| Puhto, T | 1 |
| Junttila, IS | 1 |
| Parlak, E | 1 |
| Parlak, M | 1 |
| Atli, SB | 1 |
| Hofinger, DM | 1 |
| Cardona, L | 1 |
| Mertz, GJ | 1 |
| Davis, LE | 1 |
| Meyer, MA | 1 |
| Skoczyńska, A | 1 |
| Kadłubowski, M | 1 |
| Empel, J | 1 |
| Hryniewicz, W | 1 |
| Toumi, A | 1 |
| Loussaief, C | 1 |
| Ben Yahia, S | 1 |
| Ben Romdhane, F | 1 |
| Khairallah, M | 1 |
| Chakroun, M | 1 |
| Bouzouaïa, N | 1 |
| Ishikawa, T | 1 |
| Takata, T | 1 |
| Tsuboi, Y | 1 |
| Fujiki, F | 1 |
| Takamatsu, Y | 1 |
| Tamura, K | 1 |
| Alecsandru, D | 1 |
| Gestoso, I | 1 |
| Romero, A | 1 |
| Martinez, A | 1 |
| Garcia, A | 1 |
| Lobo, J | 1 |
| Yagüe, MR | 1 |
| Rodríguez-Baño, J | 1 |
| Martí, S | 1 |
| Soto, S | 1 |
| Fernández-Cuenca, F | 1 |
| Cisneros, JM | 1 |
| Pachón, J | 1 |
| Pascual, A | 1 |
| Martínez-Martínez, L | 1 |
| McQueary, C | 1 |
| Actis, LA | 1 |
| Vila, J | 1 |
| Hakola, K | 1 |
| Savola, J | 1 |
| Burke, P | 1 |
| Burne, SR | 1 |
| Ghadage, DP | 1 |
| Bal, AM | 1 |
| Beskid, G | 2 |
| Albrecht, HA | 1 |
| Fallat, V | 1 |
| Keith, DD | 2 |
| Lipschitz, ER | 1 |
| McGarry, CM | 2 |
| McGarry, DH | 1 |
| Rossman, P | 1 |
| Siebelist, J | 2 |
| Barsić, B | 1 |
| Himbele, J | 1 |
| Beus, I | 2 |
| Schönwald, S | 2 |
| Marton, E | 1 |
| Lisić, M | 2 |
| Gogos, CA | 1 |
| Maraziotis, TG | 1 |
| Papadakis, N | 1 |
| Beermann, D | 1 |
| Siamplis, DK | 1 |
| Bassaris, HP | 1 |
| Ragunathan, PL | 1 |
| Potkins, DV | 1 |
| Watson, JG | 1 |
| Kearns, AM | 1 |
| Carroll, A | 1 |
| Cleeland, R | 1 |
| Chan, K | 1 |
| Trautmann, M | 1 |
| Ruhnke, M | 1 |
| Borner, K | 1 |
| Car, V | 1 |
| Gmajnicki, B | 1 |
| Asperilla, MO | 1 |
| Smego, RA | 1 |
| Millar, MR | 1 |
| Bransby-Zachary, MA | 1 |
| Tompkins, DS | 1 |
| Hawkey, PM | 1 |
| Myles Gibson, R | 1 |
| Hackbarth, CJ | 1 |
| Chambers, HF | 1 |
| Stella, F | 1 |
| Shibl, AM | 1 |
| Sande, MA | 2 |
| Brooks-Fournier, RA | 1 |
| Gerberding, JL | 1 |
| Wolff, M | 1 |
| Boutron, L | 1 |
| Singlas, E | 1 |
| Clair, B | 1 |
| Decazes, JM | 1 |
| Regnier, B | 1 |
2 reviews available for ciprofloxacin and Pachymeningitis
| Article | Year |
|---|---|
Tularemic meningitis in the United States.
Topics: Administration, Oral; Adult; Chloramphenicol; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, | 2009 |
Neurologic complications of anthrax: a review of the literature.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Central Nervous System Infections; Ciprofloxacin | 2003 |
22 other studies available for ciprofloxacin and Pachymeningitis
| Article | Year |
|---|---|
Positive Francisella tularensis meningitis outcome despite delayed identification: a case report.
Topics: Ciprofloxacin; Female; Francisella tularensis; Humans; Meningitis; Polymerase Chain Reaction; Tulare | 2023 |
Unusual cause of fatal anthrax meningitis.
Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Meningitis; Middle Age | 2015 |
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin | 2005 |
[Meningitis revealing Rickettsia typhi infection].
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Meningitis; Middle Aged; Retina; Rickettsia In | 2007 |
[Legionnaires' disease asssociated with meningitis and cerebellar ataxia].
Topics: Anti-Infective Agents; Cerebellar Ataxia; Ciprofloxacin; Consciousness Disorders; Humans; Legionnair | 2006 |
E. coli multiresistant meningitis after transrectal prostate biopsy.
Topics: Acute Disease; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxaci | 2006 |
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; B | 2008 |
[Meningitis caused by Francisella Tularensis].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Francisella tularensis; | 1996 |
Allergy associated with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Hypersensitivity | 2000 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; | 2002 |
In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bac | 1991 |
Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Humans; Meningitis; Meningitis, Viral; Middle Aged; Tube | 1991 |
Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Female; Humans; Infusions, Intravenous; Male; Meningitis; Mi | 1991 |
Neonatal meningitis due to Salmonella typhimurium treated with ciprofloxacin.
Topics: Ciprofloxacin; Humans; Infant, Newborn; Meningitis; Salmonella Infections; Salmonella typhimurium | 1990 |
In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Evaluation, Pr | 1990 |
Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis.
Topics: Adult; Aged; Ciprofloxacin; Female; Humans; Male; Meningitis; Meningitis, Viral; Middle Aged; Tuberc | 1990 |
Ciprofloxacin in the treatment of gram-negative bacillary meningitis.
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Gram-Negative Bacteria; Humans; Male; Meni | 1989 |
Eosinophilic meningitis associated with ciprofloxacin.
Topics: Adult; Ciprofloxacin; Eosinophilia; Female; Humans; Meningitis | 1989 |
Ciprofloxacin for Pseudomonas aeruginosa meningitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Meningitis; Middle Ag | 1986 |
Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
Topics: Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Meningitis; Pseudomonas aeruginosa; Pse | 1986 |
Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacteria | 1987 |
Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Humans; Kinetics; Male; Me | 1987 |